Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 1995.09 is in line with its estimated 1-year average of 1890.32, around the middle of its estimated 1-year range (1498.35–2214.55).
As of 2026-10-06T18:28:27.413Z.
Calculation as of: 2026-10-06T18:28:27.413Z.
Quote observation: 2026-10-06T18:25:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ad03cc2eaddb42082332b148aee8d6851fa015397d59a0785f41cacae5aa3ea4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
1995.09
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
17.19
median of 235 covered companies
CURRENT VS SECTOR MEDIAN
+11506.11%
vs the sector median at left
Starling Oncology, Inc.
Market Cap
$654.39M
Price/OCF Ratio
1995.09
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$668.50M
Price/OCF Ratio
14.49
TTM Avg
11.83
3Y Avg
25.95
5Y Avg
25.95
Market Cap
$671.30M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Starling Oncology, Inc. (STLN) | $654.39M | 1995.09 | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $666.64M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $670.12M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $668.50M | 14.49 | 11.83 | 25.95 | 25.95 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $667.42M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $671.30M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $642.95M | N/A | 72.20 | 236.60 | 236.60 |
| Aura Biosciences, Inc. (AURA)vs › | $636.65M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $635.77M | N/A | N/A | N/A | N/A |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $629.58M | 18.85 | 42.15 | 42.15 | 29.81 |
P/OCF Ratio
1995.1
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 1978.96 |
| 2026-10-02 | 1994.66 |
| 2026-10-01 | 1953.83 |
| 2026-09-30 | 1985.24 |
| 2026-09-29 | 2044.92 |
| 2026-09-28 | 2085.76 |
| 2026-09-25 | 2092.04 |
| 2026-09-24 | 2044.92 |
| 2026-09-23 | 2142.30 |
| 2026-09-22 | 2214.55 |
| 2026-09-21 | 2145.44 |
| 2026-09-18 | 2186.28 |
| 2026-09-17 | 2082.62 |
| 2026-09-16 | 2051.21 |
| 2026-09-15 | 2000.95 |
| 2026-09-14 | 2048.07 |
| 2026-09-11 | 1938.12 |
| 2026-09-10 | 1947.55 |
| 2026-09-09 | 1975.82 |
| 2026-09-08 | 1985.24 |
| 2026-09-04 | 1862.73 |
| 2026-09-03 | 1875.30 |
| 2026-09-02 | 1912.99 |
| 2026-09-01 | 1865.88 |
| 2026-08-31 | 1856.45 |
| 2026-08-28 | 1938.12 |
| 2026-08-27 | 1991.52 |
| 2026-08-26 | 2060.63 |
| 2026-08-25 | 1978.96 |
| 2026-08-24 | 1925.56 |
| 2026-08-21 | 2032.36 |
| 2026-08-20 | 2054.35 |
| 2026-08-19 | 2092.04 |
| 2026-08-18 | 2010.37 |
| 2026-08-17 | 1982.10 |
| 2026-08-14 | 2026.08 |
| 2026-08-13 | 1966.39 |
| 2026-08-12 | 1985.24 |
| 2026-08-11 | 1947.55 |
| 2026-08-10 | 1934.98 |
| 2026-08-07 | 2013.51 |
| 2026-08-06 | 1567.46 |
| 2026-08-05 | 1580.03 |
| 2026-08-04 | 1624.00 |
| 2026-08-03 | 1611.44 |
| 2026-07-31 | 1526.63 |
| 2026-07-30 | 1592.59 |
| 2026-07-29 | 1498.35 |
| 2026-07-28 | 1554.90 |
| 2026-07-27 | 1630.28 |
| 2026-07-24 | 1564.32 |
| 2026-07-23 | 1592.59 |
| 2026-07-22 | 1661.70 |
| 2026-07-21 | 1705.67 |
| 2026-07-20 | 1727.66 |
| 2026-07-17 | 1680.54 |
| 2026-07-16 | 1652.27 |
| 2026-07-15 | 1777.92 |
| 2026-07-14 | 1972.68 |
| 2026-07-13 | 1963.25 |
| 2026-07-10 | 1850.17 |
| 2026-07-09 | 1837.60 |
| 2026-07-08 | 1774.78 |
| 2026-07-07 | 1821.90 |
